ChinaBulls
Request access
Close

Anticov Biotech安谛康生物

Biotech/Healthcare

Anticancer Bioscience has developed a pipeline of innovative drugs that includes a single-dose treatment for influenza, an oral treatment for COVID-19, therapies targeting RSV and other respiratory viruses, and a potential cure for endometriosis. Its oral COVID-19 drug CN-2021 is scheduled to enter…

Source: ChinaBulls — chinabulls.com

Last updated 2022-04-01

Funding Rounds

  • Pre Series A
    RaisedFunding amount requires an account.

    Create Account to Unlock Full Data for Free

    SIGN UP

Anticov Biotech Fundraising Info

Company fundraising information requires an account.

Anticov Biotech Investors and Backers

Unlock Full Data for Free

Get access to market data, insights, backers, analytics and funding rounds.

SIGN UP